Tamsulosin hydrochloride
The active substance of Uprox XR is tamsulosin. Tamsulosin is a selective alpha-adrenergic receptor antagonist. Tamsulosin reduces the tension of the smooth muscles of the prostate and urethra, facilitating the flow of urine through the urethra and urination. Additionally, tamsulosin reduces the feeling of pressure on the bladder. Uprox XR is used to treat symptoms of lower urinary tract disorders associated with benign prostatic hyperplasia (enlargement of the prostate). These symptoms include difficulty urinating (weak stream), urinating in drops, pressure on the bladder, and increased frequency of urination both at night and during the day.
Before starting treatment with Uprox XR, discuss it with your doctor.
Uprox XR should not be used in children and adolescents under 18 years of age, as it is not effective in this population.
Taking Uprox XR with other medicines in the same group (alpha-adrenergic receptor antagonists) may cause unintended lowering of blood pressure. Tell your doctor or pharmacist about all medicines you are taking, have recently taken, or plan to take. It is especially important to tell your doctor if you are taking medicines that may reduce the excretion of Uprox XR from the body, such as ketoconazole (an antifungal medicine) or erythromycin (an antibiotic).
Uprox XR can be taken with or without food.
Uprox XR is not indicated for use in women. There have been reports of ejaculation disorders in men. This means that semen does not flow through the urethra but instead flows back into the bladder (retrograde ejaculation) or the volume of ejaculate (semen) is reduced or does not occur. This phenomenon is not a threat.
The effect of Uprox XR on the ability to drive and use machines has not been proven. However, you should be aware of the possibility of dizziness - in such cases, do not perform tasks that require attention.
Always take this medicine exactly as your doctor has told you. If you are not sure, ask your doctor or pharmacist. The recommended dose is one tablet once a day. Uprox XR can be taken with or without food, preferably at the same time every day. Swallow the tablet whole, do not chew or crush it. Uprox XR is usually prescribed for long-term use. The effect on the bladder and urination persists during long-term treatment with Uprox XR.
Taking too many Uprox XR tablets may lead to unintended lowering of blood pressure and increased heart rate with a feeling of weakness. If you have taken too many Uprox XR tablets, contact your doctor immediately.
If you miss a dose of Uprox XR, you can take the tablet later that day. If you do not take the tablet on a given day, continue treatment according to the previous dosing schedule. Do not take a double dose to make up for a missed dose (tablet).
If treatment is stopped prematurely, the symptoms of the disease may return. Therefore, you should take Uprox XR for as long as your doctor has prescribed, even if the symptoms of the disease have disappeared. Stopping treatment should always be discussed with your doctor. If you have any further questions about the use of this medicine, ask your doctor or pharmacist.
Like all medicines, Uprox XR can cause side effects, although not everybody gets them.
Uncommon(more than 1 in 1,000, but less than 1 in 100 people (0.1-1%)):
Rare(more than 1 in 10,000, but less than 1 in 1,000 people (0.01-0.1%)):
Very rare(less than 1 in 10,000 people (<0.01%)):
Not known(frequency cannot be estimated from available data):
If you are scheduled to undergo eye surgery for cataracts or increased eye pressure (glaucoma) and have taken or are taking Uprox XR, consider that the pupil may not dilate properly and the iris (colored, round part of the eye) may become flaccid during the procedure.
If you experience any side effects, including those not listed in this leaflet, please inform your doctor or pharmacist. Side effects can be reported directly to the Department of Drug Safety Monitoring, Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products, Al. Jerozolimskie 181C, 02-222 Warsaw, tel.: +48 22 49 21 301, fax: +48 22 49 21 309, website: https://smz.ezdrowie.gov.pl. By reporting side effects, you can help gather more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children. Do not use this medicine after the expiry date stated on the carton after "EXP" and on the blister after "EXP". The expiry date refers to the last day of that month. Store in the original package to protect from light. Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.
Hypromellose, microcrystalline cellulose, carbomer, colloidal anhydrous silica, iron oxide red (E 172), magnesium stearate.
Microcrystalline cellulose, hypromellose, carbomer, colloidal anhydrous silica, magnesium stearate.
Prolonged-release tablet. White, round tablet without a dividing line, 9 mm in diameter, with "T9SL" on one side and "0,4" on the other. Blister packs in a carton. One pack contains 30, 60, or 90 prolonged-release tablets.
Recordati Polska sp. z o.o. Al. Armii Ludowej 26 00-609 Warsaw
Synthon BV Microweg 22 6545 CM Nijmegen Netherlands Synthon Hispania S.L. Castelló, 1 Sant Boi de Llobregat 08830 Barcelona Spain
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.